HCV ADVOCATE WEEKLY NEWS REVIEW

[Guest guest]

HCV ADVOCATE WEEKLY NEWS REVIEW:A Review of HCV, HBV and HIV/HCV Coinfection Related News and HighlightsWeek Ending: November 2nd , 2007Alan FranciscusEditor-in-ChiefTo download pdf version click hereThis Issue:

Hepatitis called 'silent epidemic' in Hawaii Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody Homelessness increases risk of infection for injecting drug users Efficacy, safety, and changes in angiogenic markers following sunitinib monotherapy in patients with advanced hepatocellular carcinoma: Experience from a phase II study: Abstract PR 7 Inovio Biomedical's DNA Vaccine Delivery Technology Moves Ahead in Clinical Trial for Hepatitis C Vertex Expands Its Pipeline Significant New Data on Roche's PEGASYS® and Hepatitis C Pipeline Compounds to be Featured at 58th Annual AASLD Meeting Schering-Plough Highlights PEGINTRON Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting The Next Hepatitis C Blockbuster? Ignorance fuels spread of hepatitis B New Hepatitis C Antiviral CB5300 Identified by Canopus BioPharma Researchers to Enter Clinical Trial Assessment Half of UK Students at Risk of Silent Time Bomb Disease Merck Buys License to Sell New Vaccine for Hepatitis Setback in search for hepatitis C treatment EACS: Studies underline the need for better hepatitis C treatment Phase II Study Shows that Nitazoxanide Significantly Improves Response to Standard of Care in Patients with Chronic Hepatitis C Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C Roche's Oral Polymerase Inhibitor Shows Robust Antiviral Efficacy in Treatment of Chronic Hepatitis C No racial differences seen in outcomes after liver transplantation